TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Extended progression-free survival in two patients with alveolar soft part sarcoma exposed to tivantinib.

John M Goldberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.